Results Descriptive analysis From 2018 quarter 1 to 2022 quarter 4 of 2018, 57, 74, 51, 20, and 2 reports of SSIBs associated with semaglutide, liraglutide, dulaglutide, exenatide, and albiglutide, respectively, were identified in the FAERS database
How IGF-1 LR3 Works IGF-1 LR3 functions by binding to the IGF-1 receptor, activating intracellular signaling pathways that promote protein synthesis, muscle fiber hypertrophy, and nutrient uptake
Long-acting glucagon-like peptide-1 receptor agonists suppress voluntary alcohol intake in male wistar rats
Semaglutide GLP-1 is administered in varying dosages, starting at a lower dose that typically scales up to a maintenance dose as the individuals body becomes accustomed to the medication
Rather than mimicking GHRH, it activates the second growth hormone release pathway
HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: updated results